OxyPharma AB

Phadia AB

PolyPeptide Laboratories AB

Sandart & Partners Advokatbyrå KB

Stockholm Business Region

Syntagon AB

Unilabs AB

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Nya frysar för ultralåga temperaturer

TSX-frysarna från Thermo Fisher Scientific sparar på miljön och kan rymma 600 boxar med prover.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Mettler-Toledo AB

Swedish Labtech

The Swedish Foundation for Strategic Research

Vitrolife AB

WIRTH EMBALLAGE

Anna Törner: ”Orphan designation läkemedelsutvecklingens ’petite robe noire’”

Det är så lätt att klamra sig fast vid olika regulatoriska incitament, som orphan designation, utan att egentligen veta vad de innebär och på vilket sätt de kan...

Novozymes Biopharma Sweden AB

Octanorm Nordic AB

Ström & Gulliksson AB

Pfizer buys Swiss vaccines

Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.

Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”

It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Miab Mälarinvest AB